The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Merck Serono No. 1 in Infertility Treatment Market through Ninkatsu Image Strategy
July 2, 2012
- M3, Mediscience, MIC Medical Consider Capital, Operational Alliance to Establish 650 CRAs Structure
June 29, 2012
- Teva Pharma to Streamline Overlapping Products in 3 years: President Shimada
June 29, 2012
- Bayer Yakuhin to Transfer 3 Established Products to FFP
June 29, 2012
- NDA Filed for Gout Treatment Topiroxostat: Fuji Yakuhin, Sanwa Kagaku
June 29, 2012
- FDA Accepts NDA for Ospemifene for VVA: Shionogi
June 29, 2012
- AnGes MG Obtains Exclusive Rights for Vaccine for Precancerous Condition of the Cervix in China
June 28, 2012
- Takeda Ranked No. 1 in Medical Category for 5th Year in a Row: Popularity Rankings for Career Change
June 28, 2012
- DSP Launches Myslee Generic on June 28
June 28, 2012
- Eisai to Make Full-Scale Entry into Russian Market; Antiepileptic Agent Obtains Approval
June 28, 2012
- Yoshindo to Accumulate Know-How to Develop Biopharmaceutical Products through Contract Manufacturing
June 28, 2012
- Astellas Files MAA for Anti-Androgen Agent MDV3100 in Europe
June 28, 2012
- Chugai Applies for Tarceva for NSCLC First-Line Therapy
June 28, 2012
- Takata Seiyaku to Market 3 Products from Shionogi
June 28, 2012
- MSs Want “Client Visits by MRs” for Generic Promotion: Toho Pharmaceutical Survey
June 27, 2012
- Large Number of GEs Could Become Serious Issue: Alfresa Logistics Chief Fukujin
June 27, 2012
- Takeda to Market Iron Deficiency Anemia Drug in Europe
June 27, 2012
- DSP to Ship Almarl under New Brand Name from Mid-July
June 27, 2012
- Azilva Ranks No. 1 Both in GP, HP Market in May: Rep Track Survey
June 27, 2012
- Astellas Launches Kiklin Capsules, Copromotes with SKK
June 26, 2012
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…